Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07166133 · ClinicalTrials.gov registry record · NA
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
A NA study, sponsored by W.L.Gore & Associates.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT07166133 is a NA study that is actively recruiting participants, run by W.L.Gore & Associates. The registered enrollment target is 125 participants.
The verdict
NCT07166133, a NA study, is actively recruiting participants, sponsored by W.L.Gore & Associates.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
Interventions
- DEVICE GORE® TAG® Thoracic Branch Endoprosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2026-03-02 |
| Est. Completion | 2036-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07166133
The ClinicalTrials.gov registry entry for NCT07166133 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GORE® TAG® Thoracic Branch Endoprosthesis is the first listed.
NCT07166133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07166133 about?
NCT07166133 is a clinical study titled "GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study". A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
What is the current status of trial NCT07166133?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2026-03-02. Estimated completion is 2036-03.
What interventions are being tested in trial NCT07166133?
The interventions under investigation include: GORE® TAG® Thoracic Branch Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT07166133?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.